e-Article
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
02692813